https://www.finanzen.net/nachricht/aktien/world-immuno-oncology-diagnostics-markets-2022-2026-shifting-role-of-diagnostics-multiplexing-and-foundation-one-the-disruption-dynamic-the-race-for-biomarkers-the-next-five-years-10837057 Generex